Panosome GmbH
PrivateLast Round
Grant
Jun 29, 2024
Total Funding Raised
$3.61M
Company Overview
Panosome GmbH is a biotechnology company developing antibodies for challenging target classes such as carbohydrates, peptides, and small molecules for indications ranging from cancer to autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panosome GmbH Comparables
Compare Panosome GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biocognon | 75% | |
| Integral Molecular, Inc. | 74% | |
| AbCellera Biologics Inc. | 70% |
Panosome GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 29, 2024 | ||||
| Early Funding | May 21, 2024 | ||||
| Grant | May 21, 2024 |
Panosome GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bundesministerium für Bildung und Forschung | Grant |
| Encourage Ventures | Early Funding |
Panosome GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Panosome GmbH's valuation, stock price, and market status.
Is Panosome GmbH a public or private company?
Panosome GmbH is a private company.
What is the current stock price of Panosome GmbH?
Panosome GmbH is a private company with no public stock price. No recent secondary market data is available.
How much is Panosome GmbH worth (valuation)?
Valuation information for Panosome GmbH is not publicly available.
Can I buy Panosome GmbH stock?
Panosome GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Panosome GmbH's last funding round?
Panosome GmbH's most recent funding round was Grant on June 29, 2024.
Who are the main investors in Panosome GmbH?
Key investors in Panosome GmbH include Bundesministerium für Bildung und Forschung, Encourage Ventures.
Will Panosome GmbH IPO soon?
No public IPO plans have been announced for Panosome GmbH.
How can I track Panosome GmbH secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Panosome GmbH's secondary market activity and sign up for updates.